Cellectis and Lonza form biomanufacturing partnership
Lonza is to collaborate with France’s Cellectis SA for the development and commercialisation of a bioengineered cell line.
Lonza is to collaborate with France’s Cellectis SA for the development and commercialisation of a bioengineered cell line.
CRL shareholder Jana Partners has said the attempt to buy WuXi PharmaTech is the “wrong path” and it will vote against the deal.